Last updated on June 2017

Patients needed for high triglyceride / high cholesterol study "Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm, 12-week Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in Patients With Fasting Triglyceride ≥ 500 mg/dL and ≤ 1500 mg/dL"


Brief description of study

Patients needed for high triglyceride / high cholesterol study "Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm, 12-week Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in Patients With Fasting Triglyceride ≥ 500 mg/dL and ≤ 1500 mg/dL"

Detailed Study Description

A multicenter, prospective, randomized, double-blind, placebo-controlled, parallel arm, 12-week study designed to evaluate the safety and efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in patients with fasting triglyceride ≥ 500 mg/dL and ≤ 1500 mg/dL.

Clinical Study Identifier: TX150193

Find a site near you

Start Over

Cedar Crosse Research Center

800 S Wells, Suite M15 Chicago, IL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.